Micron Medical

12 articles about Micron Medical

• Micron Medical Issues a Letter to Shareholders - Jan 07, 2021

  1/7/2021

  Micron Medical, a privately-held medical device company engaged in the development, manufacture and early stage commercialization of innovative wireless, minimally invasive, electroceutical solutions for urological conditions, focused on OAB, published a letter to shareholders.

• Micron Medical to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event

  1/5/2021

  Micron Medical, a privately-held medical device company engaged in the development, manufacture and early stage commercialization of innovative wireless, minimally invasive, electroceutical solutions for urological conditions, focused on OAB, announced that it will participate in the 10th Annual LifeSci Partners Corporate Access Event, January 6-8 and 11-14, 2021.

• Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference

  12/10/2020

  Micron Medical (“Micron” or “the Company”), a privately-held, commercial stage medical device company preparing to launch a revolutionary minimally invasive neurostimulator for treating patients suffering with an overactive bladder (OAB), today announced that it will be presenting at the 13th Annual LD Micro Main Event virtual investor conference

• Micron Medical Hosting Key Opinion Leader Webinar on Protect PNS: A Percutaneous Wireless Micro-Neurostimulation Technology for Overactive Bladder December 9 at 11am EST

  12/1/2020

  Micron Medical (“Micron” or “the Company”), a privately-held medical device company engaged in the development, manufacture and pre-commercialization of innovative wireless, minimally invasive, electroceutical solutions for urological conditions, today announced that it will host a key opinion leader (KOL) webinar on its Protect PNS system for overactive bladder (OAB) on Wednesday, December 9, 2020, at 11:00 AM Eastern Time.

• Micron Medical Appoints Seasoned Healthcare Executive Mark Landy as Chief Executive Officer

  10/2/2020

  Micron Medical (“Micron” or “the Company”), a privately-held medical device company engaged in the development, manufacture and pre-commercialization of innovative wireless, minimally invasive, electroceutical solutions for urological conditions, today announced the appointment of Dr. Mark Landy as Chief Executive Officer, effective immediately. Dr. Landy, who is also joining the Company’s board of directors, has over 20 years of global leade

• Micron Medical Receives FDA 510(k) Clearance for MOVENTIS PNS, a Drug-Free Wireless Peripheral Nerve Stimulator System for Common Urological Conditions; Commercial Launch Underway

  9/14/2020

  Submits De Novo 510(k) for Protect PNS for Treatment of OAB Symptoms

• Micron Medical to Present at the LifeSci Partners Summer Symposium

  7/29/2020

  Micron Medical, a privately-held medical device company engaged in the development, manufacture and pre-commercialization of innovative wireless, minimally invasive, electroceutical solutions for urological conditions, today announced that Stephen Deitsch, Chief Executive Officer, and Laura Perryman, Inventor and Chief Operating Officer, will present a corporate overview at the Private Healthcare Company Virtual Summer Symposium, hosted by Li

• Micron Medical Appoints Veteran Medtech Executive Nick Ansari as Senior Vice President of Sales

  7/28/2020

  Micron Medical, a privately-held medical device company engaged in the development, manufacture and pre-commercialization of innovative wireless, minimally invasive, electroceutical solutions for urological conditions, today announced the appointment of Nick Ansari as Senior Vice President of Sales. Mr. Ansari has an impressive track record of success with more than 25 years of experience in field sales and commercialization in the medical de

• Micron Medical Appoints Seasoned Urology Executive Matthew Kemp as Chief Commercial Officer

  6/15/2020

  Mr. Kemp Will Build Micron Medical’s Commercial Organization and Prepare Company for Market Launch of First and Only Implantable Nerve Stimulator System for Overactive Bladder

• Micron Medical Appoints Fortune 500 Financial Executive Chris Lewis and Healthcare Industry Veteran David Kaysen to Board of Directors

  5/26/2020

  Lewis and Kaysen each bring decades of global industry expertise and senior leadership to the urology wireless neurostimulation venture

• Leading Urology KOLs Host Live Webinar Entitled “The Protect PNS for OAB: A Wireless Uro-Stimulation Injectable Technology” on April 29 at 5pm ETFeaturing Office Based Neuromodulation Solutions from Micron Medical

  4/14/2020

  Micron Medical announced that it will host a webinar entitled “The Protect PNS for OAB: A Wireless Uro-Stimulation Injectable Technology,” on Wednesday, April 29, 2020 at 5pm Eastern Time.

• StimGuard Announces Corporate Name Change to Micron Medical and Appointment of CEO as part of Expansive Executive Management TeamMicron Medical Expects U.S. Commercial Launch of Protect PNS for Treatment of Overactive Bladder in Q3 2020

  4/3/2020

  StimGuard LLC, a privately-held medical device company engaged in the development, manufacture and pre-commercialization of innovative wireless, injectable electroceutical device solutions for urological conditions, announced that it is changing its corporate name to Micron Medical Corporation.